Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Radiology
|
April 29, 2005
Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment--systematic review
Joanna M Wardlaw, Orell Mielke
Immunotherapy
|
May 17, 2018
IgPro20, the Polyneuropathy and Treatment with Hizentra<sup>®</sup> study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG
Melvin Berger, Thomas Harbo, David R Cornblath, et al.
Stroke
|
October 16, 2004
Transient ischemic attacks are more than "ministrokes"
Michael Daffertshofer, Orell Mielke, Arne Pullwitt, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
June 26, 2004
Early motor evoked potentials in acute stroke: adjunctive measure to MRI for assessment of prognosis in acute stroke within 6 hours
Johannes C Wöhrle, Stephan Behrens, Orell Mielke, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 11, 2020
Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study
Vera Bril, Hans-Peter Hartung, John-Philip Lawo, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 22, 2021
Electrophysiological predictors of response to subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy
Monica Alcantara, Hans-Peter Hartung, John-Philip Lawo, et al.
Transfusion
|
August 2, 2022
Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations
Hillary Cuesta, Ibrahim El Menyawi, Alphonse Hubsch, et al.
Stroke
|
March 10, 2007
Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study
Joanna M Wardlaw, Andrew J Farrall, David Perry, et al.
Transfusion
|
August 26, 2017
Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility
Orell Mielke, Stefano Fontana, Vesselina Goranova-Marinova, et al.
Journal of the Peripheral Nervous System : JPNS
|
March 10, 2022
Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy
Ingemar S J Merkies, Ivo N van Schaik, Vera Bril, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Radiology
|
April 29, 2005
Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment--systematic review
Joanna M Wardlaw, Orell Mielke
Immunotherapy
|
May 17, 2018
IgPro20, the Polyneuropathy and Treatment with Hizentra<sup>®</sup> study (PATH), and the treatment of chronic inflammatory demyelinating polyradiculoneuropathy with subcutaneous IgG
Melvin Berger, Thomas Harbo, David R Cornblath, et al.
Stroke
|
October 16, 2004
Transient ischemic attacks are more than "ministrokes"
Michael Daffertshofer, Orell Mielke, Arne Pullwitt, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
June 26, 2004
Early motor evoked potentials in acute stroke: adjunctive measure to MRI for assessment of prognosis in acute stroke within 6 hours
Johannes C Wöhrle, Stephan Behrens, Orell Mielke, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
October 11, 2020
Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study
Vera Bril, Hans-Peter Hartung, John-Philip Lawo, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 22, 2021
Electrophysiological predictors of response to subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy
Monica Alcantara, Hans-Peter Hartung, John-Philip Lawo, et al.
Transfusion
|
August 2, 2022
Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations
Hillary Cuesta, Ibrahim El Menyawi, Alphonse Hubsch, et al.
Stroke
|
March 10, 2007
Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study
Joanna M Wardlaw, Andrew J Farrall, David Perry, et al.
Transfusion
|
August 26, 2017
Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility
Orell Mielke, Stefano Fontana, Vesselina Goranova-Marinova, et al.
Journal of the Peripheral Nervous System : JPNS
|
March 10, 2022
Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy
Ingemar S J Merkies, Ivo N van Schaik, Vera Bril, et al.
Page
of 2